Learn more about Evotec's regulated LC/MS bioanalysis capabilities and expertise including:
- High quality service across all phases of pre-clinical and clinical drug development in compliance with GLP and GCP regulations
- More than 25 years of experience to perform LC/MS activities in a regulated environment
- Extensive bioanalytical method development expertise to meet the most demanding and challenging client needs
- Multidisciplinary collaboration enabling integrated solutions to accelerate the drug development process
DOWNLOAD
Tags:
Fact Sheets,
Proteomics, Metabolomics & Biomarkers,
IND Enabling Studies/Preclinical Development,
Sample Management
Learn more about Evotec’s polymerase chain reaction (PCR) services including:
- Therapeutic modalities
- Sample management capabilities
- PCR applications
- Quantitative real time PCR (qPCR) and reverse transcription qPCR (RT-qPCR) applications, including copy number estimation assays, gene expression profiling and genotyping assaysRegulated PCR services
DOWNLOAD
Tags:
Fact Sheets,
Proteomics, Metabolomics & Biomarkers,
IND Enabling Studies/Preclinical Development,
Sample Management
Learn more about our ligand binding assays and how they can support biological drug testing in a regulated environment, including:
- Regulated bioanalysis
- Immunogenicity
- Immunotoxicity
- Biomarkers (safety and efficacy)
- Clinical Pathology
- Sample Management
- Additional activities
DOWNLOAD
Tags:
Fact Sheets,
Proteomics, Metabolomics & Biomarkers,
IND Enabling Studies/Preclinical Development,
Toxicology & Safety,
Sample Management
Learn more about human pharmacokinetic prediction including:
- background information on the predictive model
- in vitro ADME data and structural data requirements for PK prediction
- data delivered for the PK prediction
- validation data for the predictive model
DOWNLOAD
Tags:
Fact Sheets,
ADME/DMPK,
Modelling and Simulation
The Hollow Fibre Infection Model (HFIM) is a dynamic in vitro system for the determination of PK/PD relationships between antimicrobial compounds and bacteria, fungi or viruses.
Evotec has developed its own dedicated state-of-the-art BSL2 facility offering it partners a bespoke in vitro PK/PD service tailored to advance their individual antimicrobial development programs.
DOWNLOAD NOW
Tags:
Antibiotic Resistance,
infectious diseases,
Fact Sheets,
In vitro Biology,
Anti-Infectives
Learn more about the brain tissue binding assay including:
- Background information
- Assay details and protocol summary
- Data generated in the brain tissue binding assay
DOWNLOAD
Tags:
Fact Sheets,
ADME/DMPK
Learn more about the cytochrome P450 time dependent inhibition (CYP TDI) single point assay including:
- background information
- assay details and protocol summary
- assay data generated in the CYP TDI single point assay
DOWNLOAD
Tags:
Fact Sheets,
ADME/DMPK
Learn more about the cytochrome P450 time dependent inhibition (CYP TDI) IC50 shift assay including:
- Background information
- Assay details and protocol summary
- Data generated in the CYP TDI IC50 shift assay
DOWNLOAD
Tags:
Fact Sheets,
ADME/DMPK
Learn more about the cytochrome P450 time dependent inhibition (CYP TDI) kinact/KI assay including:
- Background information
- Assay details and protocol summary
- Data generated in the CYP TDI kinact/KI assay
DOWNLOAD
Tags:
Fact Sheets,
ADME/DMPK
Learn more about CYP inhibition (Ki) including:
- Background information
- Assay details and protocol summary
- Data generated in the CYP inhibition (Ki) assay
DOWNLOAD
Tags:
Fact Sheets,
ADME/DMPK